» Articles » PMID: 34086193

Clinical Frailty Score As an Independent Predictor of Outcome in COVID-19 Hospitalised Patients

Overview
Journal Eur Geriatr Med
Specialty Geriatrics
Date 2021 Jun 4
PMID 34086193
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of The Study: We explored potential predictive variables associated with outcomes using baseline clinical parameters of 500 hospitalised patients with COVID -19 in a single centre, UK.

Methods: Retrospective study collecting demographic and clinical characteristics of patients admitted at Southend University Hospital from 20th February to 7th May 2020.

Results: The mean age of the cohort admitted to hospital with Covid-19 was 69.4 and 58% were over 70. Comorbidities were more frequently observed in non-survivors, whose mean Clinical Frailty Scale was significantly higher (5 vs 3) than survivors, p < 0.001. In addition, mean C-reactive protein was significantly higher.

Conclusion: Older and frailer patients with high inflammatory markers were at risk of poor outcomes. Integrated frailty and age-based risk stratification is essential, in addition to monitoring saturation /FiO2 ratio (SFR) and inflammatory markers throughout the disease course to allow for early intervention to improve patient outcomes. A frailty-based risk-stratification approach, rather than age may prove more valuable when considering interventions in patients with multiple comorbidities.

Citing Articles

Enhancing the Understanding of Abdominal Trauma During the COVID-19 Pandemic Through Co-Occurrence Analysis and Machine Learning.

Radulescu D, Calafeteanu D, Radulescu P, Boldea G, Mercut R, Ciupeanu-Calugaru E Diagnostics (Basel). 2024; 14(21).

PMID: 39518411 PMC: 11544937. DOI: 10.3390/diagnostics14212444.


Blood circulating bacterial DNA in hospitalized old COVID-19 patients.

Giacconi R, DAquila P, Cardelli M, Piacenza F, Pierpaoli E, Sena G Immun Ageing. 2023; 20(1):76.

PMID: 38111002 PMC: 10726536. DOI: 10.1186/s12979-023-00401-4.


Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19.

Matsumoto C, Shibata S, Kishi T, Morimoto S, Mogi M, Yamamoto K Hypertens Res. 2022; 46(3):601-619.

PMID: 36575228 PMC: 9793823. DOI: 10.1038/s41440-022-01145-2.


Performance status: A key factor in predicting mortality in the first wave of COVID-19 in South-East Scotland.

Mutch C, Ross D, Bularga A, Cave R, Chase-Topping M, Anand A J R Coll Physicians Edinb. 2022; 52(3):204-212.

PMID: 36369813 PMC: 9659484. DOI: 10.1177/14782715221120137.


Geriatric syndromes and functions in older adults with COVID-19 hospitalized in sub-acute care: a multicenter study.

Morandi A, Gual N, Cesari M, Mota M, Butto V, Gentile S Aging Clin Exp Res. 2022; 35(1):221-226.

PMID: 36280623 PMC: 9591316. DOI: 10.1007/s40520-022-02264-z.


References
1.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

2.
Bellelli G, Rebora P, Valsecchi M, Bonfanti P, Citerio G . Frailty index predicts poor outcome in COVID-19 patients. Intensive Care Med. 2020; 46(8):1634-1636. PMC: 7246290. DOI: 10.1007/s00134-020-06087-2. View

3.
Rice T, Wheeler A, Bernard G, Hayden D, Schoenfeld D, Ware L . Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest. 2007; 132(2):410-7. DOI: 10.1378/chest.07-0617. View

4.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A . Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. PMC: 7136855. DOI: 10.1001/jama.2020.5394. View

5.
Hewitt J, Carter B, Vilches-Moraga A, Quinn T, Braude P, Verduri A . The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020; 5(8):e444-e451. PMC: 7326416. DOI: 10.1016/S2468-2667(20)30146-8. View